Pancreatic Cancer: Pancreatica - 2003: October - November

Pancreatic Cancer News and Archives

For access to the Select Abstracts^sm section, please click here

For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer

2003 Fourth Quarter

Identification of Maspin and S100P as Novel Hypomethylation Targets in Pancreatic Cancer Using Global Gene Expression Profiling
December 29, 2003
...more

The Effects of Staging Laparoscopy on Trocar Site and Peritoneal Recurrence of Pancreatic Cancer
December 29, 2003
...more

MUC1 and MUC2 Expression in Pancreatic Ductal Carcinoma Obtained by Fine-Needle Aspiration
December 25, 2003
...more

Activated Kras and Ink4a/Arf Deficiency Cooperate to Produce Metastatic Pancreatic Ductal Adenocarcinoma in the Mouse
December 17, 2003
...more

The C-myc and PyMT Oncogenes Induce Different Tumor Types in a Somatic Mouse Model for Pancreatic Cancer
December 17, 2003
...more

Activated Kras and Ink4a/Arf Deficiency Cooperate to Produce Metastatic Pancreatic Ductal Adenocarcinoma
December 15, 2003
...more

Highly Expressed Genes in Pancreatic Ductal Adenocarcinomas: A Comprehensive Characterization and Comparison of the Transcription Profiles Obtained from Three Major Technologies
December 15, 2003
...more

Inhibition of Platelet-Derived Growth Factor Receptor Phosphorylation by STI571 (Gleevec) Reduces Growth and Metastasis of Human Pancreatic Carcinoma in an Orthotopic Nude Mouse Model
December 15, 2003
...more

The c-myc and PyMT Oncogenes Induce Different Tumor Types in a Somatic Mouse Model for Pancreatic Cancer
December 15, 2003
...more

Phase I Trial Using a Time-to-Event Continual Reassessment Strategy for Dose Escalation of Cisplatin Combined With Gemcitabine and Radiation Therapy in Pancreatic Cancer
December 9, 2003
...more

18-Fluorodeoxyglucose Positron Emission Tomography in Predicting Survival of Patients with Pancreatic Carcinoma
December 1, 2003
...more

Aggressive Surgery for Metastatic Liver Neuroendocrine Tumors
December 1, 2003
...more

Changes in Morbidity After Pancreatic Resection: Toward the End of Completion Pancreatectomy
December 1, 2003
...more

Chemoradiotherapy in the Treatment of Regional Pancreatic Carcinoma: A Phase II Study
December 1, 2003
...more

Efficacy of Venous Reconstruction in Patients with Adenocarcinoma of the Pancreatic Head
December 1, 2003
...more

Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy of Patients with Suspected Pancreatic Cancer: Diagnostic Accuracy and Acute and 30-day Complications
December 1, 2003
...more

Extended Lymphadenectomy and Vein Resection for Pancreatic Head Cancer: Outcomes and Implications for Therapy
December 1, 2003
...more

Genetics of Neuroendocrine and Carcinoid Tumours
December 1, 2003
...more

Is Extended Resection for Adenocarcinoma of the Body or Tail of the Pancreas Justified?
December 1, 2003
...more

Prognostic Value of hMLH1 Methylation and Microsatellite Instability in Pancreatic Endocrine Neoplasms
December 1, 2003
...more

The Efficacy of Tyrosine Kinase Inhibitors on Human Pancreatic Cancer Cell Lines
December 1, 2003
...more

The Importance of the Measurement of Circulating Markers in Patients with Neuroendocrine Tumours of the Pancreas and Gut
December 1, 2003
...more

Tumoral Markers and Acute-Phase Reactants in the Diagnosis of Pancreatic Cancer
December 1, 2003
...more

Identification of Common or Distinct Genes Related to Antitumor Activities of a Medicinal Herb and Its Major Component by Oligonucleotide Microarray
November 20, 2003
...more

Occupational Exposure to Dyes, Metals, Polycyclic Aromatic Hydrocarbons and Other Agents and K-ras Activation in Human Exocrine Pancreatic Cancer
November 20, 2003
...more

A Phase II Irinotecan-Cisplatin Combination in Advanced Pancreatic Cancer
November 17, 2003
...more

Independent Review of Orathecin^(TM) Phase III Trial Supports Drug's Activity in Pancreatic Cancer Patients who Failed Prior Treatments
November 17, 2003
...more

A Novel Approach in the Treatment of Neuroendocrine Gastrointestinal Tumours. Targeting the Epidermal Growth Factor Receptor by Gefitinib (ZD1839)
November 3, 2003
...more

Angiogenesis is Continuous with Two Peaks During Azaserine-Induced Rat Pancreatic Adenocarcinoma Progression: An Electron Microscopic Morphometrical Study
November 1, 2003
...more

Considerations on Early Diagnosis of Carcinoma of the Pancreas
November 1, 2003
...more

Cystic Pancreatic Neoplasms: Enucleate or Resect?
November 1, 2003
...more

Defining the Role of the Epidermal Growth Factor Receptor in Pancreatic Cancer Grown In Vitro
November 1, 2003
...more

Glufosfamide Administered Using a 1-Hour Infusion Given as First-Line Treatment for Advanced Pancreatic Cancer. A Phase II Trial of the EORTC-New Drug Development Group
November 1, 2003
...more

Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Pancreatic Cancer: Results of Feasibility Study
November 1, 2003
...more

Lower Frequency of Peritoneal Carcinomatosis in Patients with Pancreatic Cancer Diagnosed by EUS-Guided FNA vs. Percutaneous FNA
November 1, 2003
...more

Macrophages Play a Critical Role in the Anti-Tumor Activity of Virulizin(R)
November 1, 2003
...more

Nonfunctioning Pancreatic Endocrine Tumors: A Multicenter Clinical Study
November 1, 2003
...more

Nutritional Links to Plausible Mechanisms Underlying Pancreatic Cancer: A Conference Report
November 1, 2003
...more

Pancreatic Cancer Growth is Inhibited by Blockade of VEGF-RII
November 1, 2003
...more

Transarterial Chemoembolization of Advanced Liver Metastases of Neuroendocrine Tumors - A Retrospective Single-Center Analysis
October 31, 2003
...more

Percutaneous Biopsy of Periarterial Soft Tissue Cuffs in the Diagnosis of Pancreatic Carcinoma
October 28, 2003
...more

Daily Aspirin Use Linked with Pancreatic Cancer
October 27, 2003
...more

Yield of Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy in Patients with Suspected Pancreatic Carcinoma
October 25, 2003
...more

Combination Chemotherapy and Surgery Improve Survival of Patients with Unresectable Pancreatic Cancer
October 21, 2003
...more

Prognostic Value of CA 19-9 Levels in Patients with Inoperable Adenocarcinoma of the Pancreas Treated with Gemcitabine
October 20, 2003
...more

Inserting Chromosome 18 into Pancreatic Cancer Cells Switches Them to a Dormant Metastatic Phenotype
October 15, 2003
...more

Restoration of SMAD4 by Gene Therapy Reverses the Invasive Phenotype in Pancreatic Adenocarcinoma Cells
October 9, 2003
...more

Effect of Selective Cyclooxygenase-2 Inhibitor Celebrex on Expression of Vascular Endothelial Growth Factor (VEGF)in Pancreatic Carcinoma
October 5, 2003
...more

Adjuvant Arterial Infusion Chemotherapy for Patients with Pancreatic Cancer
October 1, 2003
...more

Application of Laser Capture Microdissection Combined with Two-Dimensional Electrophoresis for the Discovery of Differentially Regulated Proteins in Pancreatic Ductal Adenocarcinoma
October 1, 2003
...more

Are Serial CA 19-9 Kinetics Helpful in Predicting Survival in Patients with Advanced or Metastatic Pancreatic Cancer Treated with Gemcitabine and Cisplatin?
October 1, 2003
...more

Chemoradiation Therapy for Stage IV Pancreatic Cancer
October 1, 2003
...more

Combined Biliary and Duodenal Stenting for Palliation of Pancreatic Cancer
October 1, 2003
...more

CT, Endoscopic Sonography, and a Combined Protocol for Preoperative Evaluation of Pancreatic Insulinomas
October 1, 2003
...more

Do Pancreatic Duct Stents Cause or Prevent Pancreatic Sepsis?
October 1, 2003
...more

Docetaxel and Radiotherapy and Pancreatic Cancer
October 1, 2003
...more

Effect of a Protein and Energy Dense N-3 Fatty Acid Enriched Oral Supplement on Loss of Weight and Lean Tissue in Cancer Cachexia: A Randomised Double Blind Trial
October 1, 2003
...more

Establishment of Gemcitabine-Resistant Human Pancreatic Cancer Cells and Effect of Brefeldin-a on the Resistant Cell Line
October 1, 2003
...more

Gemcitabine Infusion via Splenic Artery for Advanced Pancreatic Cancer
October 1, 2003
...more

Heparanase-1 Activity in Pancreatic Cancer Patient Serum Decreases After Gemcitabine Therapy
October 1, 2003
...more

Infectivity Enhanced, Cyclooxygenase-2 Promoter-based Conditionally Replicative Adenovirus for Pancreatic Cancer
October 1, 2003
...more

Infrared Laser Activation of Indocyanine Green Inhibits Growth in Human Pancreatic Cancer
October 1, 2003
...more

Intra-Arterial Infusion Chemotherapy With Angiotensin-II for Locally Advanced and Nonresectable Pancreatic Adenocarcinoma: Further Evaluation and Prognostic Implications
October 1, 2003
...more

Irinotecan (Campto) in the Treatment of Pancreatic Cancer
October 1, 2003
...more

Management of Patients at High Risk for Pancreatic Cancer
October 1, 2003
...more

Monocytes Stimulate COX-2 Expression in Pancreatic Cancer Cells
October 1, 2003
...more

Novel Chemoradiotherapy for Locally Advanced Pancreatic Cancer Using Arterial Infusion Chemotherapy Following the Alteration of Peripancreatic Blood Flow
October 1, 2003
...more

Palliation for Advanced Pancreatic Cancer: An Analysis of Cost and Clinical Outcome
October 1, 2003
...more

Phase II Trial of a 24-Hour Infusion of Gemcitabine in Previously Untreated Patients with Advanced Pancreatic Adenocarcinoma
October 1, 2003
...more

For educational purposes only; not to be relied upon
Please read Pancreatica Disclaimer

Home | In The News | Links | Newswire | Donations
FAQ | Clinical Trials Database | Research Resources | About Us

webmaster

©2000-2010 Pancreatica.org - All Rights Reserved
www.pancreatica.org

	Pancreatic Cancer News and Archives *For access to the Select Abstracts^sm section, please click here* For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer 2003 Fourth Quarter Identification of Maspin and S100P as Novel Hypomethylation Targets in Pancreatic Cancer Using Global Gene Expression Profiling December 29, 2003 ...more The Effects of Staging Laparoscopy on Trocar Site and Peritoneal Recurrence of Pancreatic Cancer December 29, 2003 ...more MUC1 and MUC2 Expression in Pancreatic Ductal Carcinoma Obtained by Fine-Needle Aspiration December 25, 2003 ...more Activated Kras and Ink4a/Arf Deficiency Cooperate to Produce Metastatic Pancreatic Ductal Adenocarcinoma in the Mouse December 17, 2003 ...more The C-myc and PyMT Oncogenes Induce Different Tumor Types in a Somatic Mouse Model for Pancreatic Cancer December 17, 2003 ...more Activated Kras and Ink4a/Arf Deficiency Cooperate to Produce Metastatic Pancreatic Ductal Adenocarcinoma December 15, 2003 ...more Highly Expressed Genes in Pancreatic Ductal Adenocarcinomas: A Comprehensive Characterization and Comparison of the Transcription Profiles Obtained from Three Major Technologies December 15, 2003 ...more Inhibition of Platelet-Derived Growth Factor Receptor Phosphorylation by STI571 (Gleevec) Reduces Growth and Metastasis of Human Pancreatic Carcinoma in an Orthotopic Nude Mouse Model December 15, 2003 ...more The c-myc and PyMT Oncogenes Induce Different Tumor Types in a Somatic Mouse Model for Pancreatic Cancer December 15, 2003 ...more Phase I Trial Using a Time-to-Event Continual Reassessment Strategy for Dose Escalation of Cisplatin Combined With Gemcitabine and Radiation Therapy in Pancreatic Cancer December 9, 2003 ...more 18-Fluorodeoxyglucose Positron Emission Tomography in Predicting Survival of Patients with Pancreatic Carcinoma December 1, 2003 ...more Aggressive Surgery for Metastatic Liver Neuroendocrine Tumors December 1, 2003 ...more Changes in Morbidity After Pancreatic Resection: Toward the End of Completion Pancreatectomy December 1, 2003 ...more Chemoradiotherapy in the Treatment of Regional Pancreatic Carcinoma: A Phase II Study December 1, 2003 ...more Efficacy of Venous Reconstruction in Patients with Adenocarcinoma of the Pancreatic Head December 1, 2003 ...more Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy of Patients with Suspected Pancreatic Cancer: Diagnostic Accuracy and Acute and 30-day Complications December 1, 2003 ...more Extended Lymphadenectomy and Vein Resection for Pancreatic Head Cancer: Outcomes and Implications for Therapy December 1, 2003 ...more Genetics of Neuroendocrine and Carcinoid Tumours December 1, 2003 ...more Is Extended Resection for Adenocarcinoma of the Body or Tail of the Pancreas Justified? December 1, 2003 ...more Prognostic Value of hMLH1 Methylation and Microsatellite Instability in Pancreatic Endocrine Neoplasms December 1, 2003 ...more The Efficacy of Tyrosine Kinase Inhibitors on Human Pancreatic Cancer Cell Lines December 1, 2003 ...more The Importance of the Measurement of Circulating Markers in Patients with Neuroendocrine Tumours of the Pancreas and Gut December 1, 2003 ...more Tumoral Markers and Acute-Phase Reactants in the Diagnosis of Pancreatic Cancer December 1, 2003 ...more Identification of Common or Distinct Genes Related to Antitumor Activities of a Medicinal Herb and Its Major Component by Oligonucleotide Microarray November 20, 2003 ...more Occupational Exposure to Dyes, Metals, Polycyclic Aromatic Hydrocarbons and Other Agents and K-ras Activation in Human Exocrine Pancreatic Cancer November 20, 2003 ...more A Phase II Irinotecan-Cisplatin Combination in Advanced Pancreatic Cancer November 17, 2003 ...more Independent Review of Orathecin^(TM) Phase III Trial Supports Drug's Activity in Pancreatic Cancer Patients who Failed Prior Treatments November 17, 2003 ...more A Novel Approach in the Treatment of Neuroendocrine Gastrointestinal Tumours. Targeting the Epidermal Growth Factor Receptor by Gefitinib (ZD1839) November 3, 2003 ...more Angiogenesis is Continuous with Two Peaks During Azaserine-Induced Rat Pancreatic Adenocarcinoma Progression: An Electron Microscopic Morphometrical Study November 1, 2003 ...more Considerations on Early Diagnosis of Carcinoma of the Pancreas November 1, 2003 ...more Cystic Pancreatic Neoplasms: Enucleate or Resect? November 1, 2003 ...more Defining the Role of the Epidermal Growth Factor Receptor in Pancreatic Cancer Grown In Vitro November 1, 2003 ...more Glufosfamide Administered Using a 1-Hour Infusion Given as First-Line Treatment for Advanced Pancreatic Cancer. A Phase II Trial of the EORTC-New Drug Development Group November 1, 2003 ...more Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Pancreatic Cancer: Results of Feasibility Study November 1, 2003 ...more Lower Frequency of Peritoneal Carcinomatosis in Patients with Pancreatic Cancer Diagnosed by EUS-Guided FNA vs. Percutaneous FNA November 1, 2003 ...more Macrophages Play a Critical Role in the Anti-Tumor Activity of Virulizin(R) November 1, 2003 ...more Nonfunctioning Pancreatic Endocrine Tumors: A Multicenter Clinical Study November 1, 2003 ...more Nutritional Links to Plausible Mechanisms Underlying Pancreatic Cancer: A Conference Report November 1, 2003 ...more Pancreatic Cancer Growth is Inhibited by Blockade of VEGF-RII November 1, 2003 ...more Transarterial Chemoembolization of Advanced Liver Metastases of Neuroendocrine Tumors - A Retrospective Single-Center Analysis October 31, 2003 ...more Percutaneous Biopsy of Periarterial Soft Tissue Cuffs in the Diagnosis of Pancreatic Carcinoma October 28, 2003 ...more Daily Aspirin Use Linked with Pancreatic Cancer October 27, 2003 ...more Yield of Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy in Patients with Suspected Pancreatic Carcinoma October 25, 2003 ...more Combination Chemotherapy and Surgery Improve Survival of Patients with Unresectable Pancreatic Cancer October 21, 2003 ...more Prognostic Value of CA 19-9 Levels in Patients with Inoperable Adenocarcinoma of the Pancreas Treated with Gemcitabine October 20, 2003 ...more Inserting Chromosome 18 into Pancreatic Cancer Cells Switches Them to a Dormant Metastatic Phenotype October 15, 2003 ...more Restoration of SMAD4 by Gene Therapy Reverses the Invasive Phenotype in Pancreatic Adenocarcinoma Cells October 9, 2003 ...more Effect of Selective Cyclooxygenase-2 Inhibitor Celebrex on Expression of Vascular Endothelial Growth Factor (VEGF)in Pancreatic Carcinoma October 5, 2003 ...more Adjuvant Arterial Infusion Chemotherapy for Patients with Pancreatic Cancer October 1, 2003 ...more Application of Laser Capture Microdissection Combined with Two-Dimensional Electrophoresis for the Discovery of Differentially Regulated Proteins in Pancreatic Ductal Adenocarcinoma October 1, 2003 ...more Are Serial CA 19-9 Kinetics Helpful in Predicting Survival in Patients with Advanced or Metastatic Pancreatic Cancer Treated with Gemcitabine and Cisplatin? October 1, 2003 ...more Chemoradiation Therapy for Stage IV Pancreatic Cancer October 1, 2003 ...more Combined Biliary and Duodenal Stenting for Palliation of Pancreatic Cancer October 1, 2003 ...more CT, Endoscopic Sonography, and a Combined Protocol for Preoperative Evaluation of Pancreatic Insulinomas October 1, 2003 ...more Do Pancreatic Duct Stents Cause or Prevent Pancreatic Sepsis? October 1, 2003 ...more Docetaxel and Radiotherapy and Pancreatic Cancer October 1, 2003 ...more Effect of a Protein and Energy Dense N-3 Fatty Acid Enriched Oral Supplement on Loss of Weight and Lean Tissue in Cancer Cachexia: A Randomised Double Blind Trial October 1, 2003 ...more Establishment of Gemcitabine-Resistant Human Pancreatic Cancer Cells and Effect of Brefeldin-a on the Resistant Cell Line October 1, 2003 ...more Gemcitabine Infusion via Splenic Artery for Advanced Pancreatic Cancer October 1, 2003 ...more Heparanase-1 Activity in Pancreatic Cancer Patient Serum Decreases After Gemcitabine Therapy October 1, 2003 ...more Infectivity Enhanced, Cyclooxygenase-2 Promoter-based Conditionally Replicative Adenovirus for Pancreatic Cancer October 1, 2003 ...more Infrared Laser Activation of Indocyanine Green Inhibits Growth in Human Pancreatic Cancer October 1, 2003 ...more Intra-Arterial Infusion Chemotherapy With Angiotensin-II for Locally Advanced and Nonresectable Pancreatic Adenocarcinoma: Further Evaluation and Prognostic Implications October 1, 2003 ...more Irinotecan (Campto) in the Treatment of Pancreatic Cancer October 1, 2003 ...more Management of Patients at High Risk for Pancreatic Cancer October 1, 2003 ...more Monocytes Stimulate COX-2 Expression in Pancreatic Cancer Cells October 1, 2003 ...more Novel Chemoradiotherapy for Locally Advanced Pancreatic Cancer Using Arterial Infusion Chemotherapy Following the Alteration of Peripancreatic Blood Flow October 1, 2003 ...more Palliation for Advanced Pancreatic Cancer: An Analysis of Cost and Clinical Outcome October 1, 2003 ...more Phase II Trial of a 24-Hour Infusion of Gemcitabine in Previously Untreated Patients with Advanced Pancreatic Adenocarcinoma October 1, 2003 ...more

	For educational purposes only; not to be relied upon Please read Pancreatica Disclaimer


	Home \| In The News \| Links \| Newswire \| Donations FAQ \| Clinical Trials Database \| Research Resources \| About Us

	webmaster

	©2000-2010 Pancreatica.org - All Rights Reserved www.pancreatica.org